Status:
NOT_YET_RECRUITING
One-Year Effect on Levodopa Equivalent Daily Dose of Thalamic VIM Nucleus Stimulation Compared to Subthalamic Nucleus Stimulation in Patients With Parkinson's Disease
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Parkinson Disease (PD)
Deep Brain Stimulation
Eligibility:
All Genders
Brief Summary
This study compares the effects of deep brain stimulation (DBS) of the thalamic VIM nucleus versus the subthalamic nucleus (STN) on the levodopa equivalent daily dose (LEDD) in patients with Parkinson...
Detailed Description
Thesis Summary: Deep brain stimulation (DBS) is a well-established therapeutic option for patients with advanced Parkinson's disease. The two most commonly targeted structures are the subthalamic nuc...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Parkinson's disease
- Underwent surgery for subthalamic nucleus (STN) or ventral intermediate nucleus (VIM) deep brain stimulation
- Surgery performed at CHRU of Nancy
- Surgery performed between 2014 (DxCare implementation) and 2024
Exclusion
- No clinical diagnosis of Parkinson's disease
- No initial dopaminergic treatment
- Surgery not performed at CHRU of Nancy
- Death within 1 year following surgery
Key Trial Info
Start Date :
April 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06936254
Start Date
April 30 2025
End Date
September 30 2026
Last Update
April 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chru Nancy
Nancy, Lorraine, France, 54000